Does Dr. STEVEN ALTMAYER have financial conflicts of interest?

Dr. STEVEN ALTMAYER (MD) has received a total of $1,028 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,028 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. STEVEN ALTMAYER?

According to CMS Open Payments data, Dr. STEVEN ALTMAYER received funding from REGENERON HEALTHCARE SOLUTIONS ($213), GALVANIZE THERAPEUTICS ($158), and ORTHO DERMATOLOGICS, A DIVISION OF BAUSCH HEALTH US ($128).

Does Dr. STEVEN ALTMAYER receive research grants or speaking fees?

Dr. STEVEN ALTMAYER has received $1,028 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. STEVEN ALTMAYER

MDReal-Time Hydrated

Specialty: Dermatology, MOHS-Micrographic Surgery

Practice Location: ALBANY, NY 12203

NPI Number: 1902069024

LIFETIME INDUSTRY VALUE

$1,028

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALTMAYER is a verified Dermatology, MOHS-Micrographic Surgery practitioner based in ALBANY, NY.

Between 2021 and 2025, Dr. ALTMAYER had an overall industry promotional and research financial footprint of $1,028 as recorded in the federal CMS Open Payments database.

$1,028 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALTMAYER's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $213 (representing 20.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$213

20.8%

GALVANIZE THERAPEUTICS

Rank 2

$158

15.4%

ORTHO DERMATOLOGICS, A DIVISION OF BAUSCH HEALTH US

Rank 3

$128

12.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.